These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 21484931

  • 1. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W, Arai Y, Kasai F, Fujiwara Y, Haruta M, Hosaka R, Nishida K, Kurosumi M, Kobayashi Y, Akagi K, Kaneko Y.
    Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC, Dos Santos AC, de Aguirre Neto JC, Nevado J, Lapunzina P, Vargas FR.
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA.
    Cancer Res; 2003 Oct 15; 63(20):6643-50. PubMed ID: 14583457
    [Abstract] [Full Text] [Related]

  • 9. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
    Barlow JW, Mous M, Wiley JC, Varley JM, Lozano G, Strong LC, Malkin D.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 15; 13(8):1403-6. PubMed ID: 15298965
    [Abstract] [Full Text] [Related]

  • 10. Germline TP53 mutations and Li-Fraumeni syndrome.
    Varley JM.
    Hum Mutat; 2003 Mar 15; 21(3):313-20. PubMed ID: 12619118
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A functional variant in miR-605 modifies the age of onset in Li-Fraumeni syndrome.
    Id Said B, Malkin D.
    Cancer Genet; 2015 Mar 15; 208(1-2):47-51. PubMed ID: 25683625
    [Abstract] [Full Text] [Related]

  • 13. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P, Illana FJ, Martín-Morales L, de la Hoya M, Garre P, Ibañez-Royo MD, Pérez-Segura P, Caldés T, García-Barberán V.
    Fam Cancer; 2017 Oct 15; 16(4):567-575. PubMed ID: 28573494
    [Abstract] [Full Text] [Related]

  • 14. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL.
    Oncogene; 2001 Jul 27; 20(33):4441-9. PubMed ID: 11494139
    [Abstract] [Full Text] [Related]

  • 15. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
    Piao J, Sakurai N, Iwamoto S, Nishioka J, Nakatani K, Komada Y, Mizutani S, Takagi M.
    Mol Carcinog; 2013 Oct 27; 52(10):770-6. PubMed ID: 22495821
    [Abstract] [Full Text] [Related]

  • 16. High frequency of de novo mutations in Li-Fraumeni syndrome.
    Gonzalez KD, Buzin CH, Noltner KA, Gu D, Li W, Malkin D, Sommer SS.
    J Med Genet; 2009 Oct 27; 46(10):689-93. PubMed ID: 19556618
    [Abstract] [Full Text] [Related]

  • 17. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
    Bougeard G, Sesboüé R, Baert-Desurmont S, Vasseur S, Martin C, Tinat J, Brugières L, Chompret A, de Paillerets BB, Stoppa-Lyonnet D, Bonaïti-Pellié C, Frébourg T, French LFS working group.
    J Med Genet; 2008 Aug 27; 45(8):535-8. PubMed ID: 18511570
    [Abstract] [Full Text] [Related]

  • 18. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
    Kappel S, Janschek E, Wolf B, Rudas M, Teleky B, Jakesz R, Kandioler D.
    Breast Cancer Res Treat; 2015 Jun 27; 151(3):671-8. PubMed ID: 25981898
    [Abstract] [Full Text] [Related]

  • 19. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM, Brondani VB, Helena VP, Charchar HLS, Zerbini MCN, Leite LAS, Hoff AO, Latronico AC, Mendonca BB, Diz MDPE, de Almeida MQ, Fragoso MCBV.
    J Steroid Biochem Mol Biol; 2019 Jun 27; 190():250-255. PubMed ID: 30974190
    [Abstract] [Full Text] [Related]

  • 20. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.
    Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P.
    Curr Opin Oncol; 2010 Jan 27; 22(1):64-9. PubMed ID: 19952748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.